Category Regulatory

Roche Showcases Breakthrough Data at ESMO 2025 Highlighting Scientific Advances and Transformative Progress in Cancer Care Across Multiple Tumor Types

Roche to Present Over 30 Oncology Abstracts at ESMO 2025, Showcasing Breakthroughs Across Major Cancer Types Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it will present more than 30 scientific abstracts spanning over 10 cancer types at the European…

Read MoreRoche Showcases Breakthrough Data at ESMO 2025 Highlighting Scientific Advances and Transformative Progress in Cancer Care Across Multiple Tumor Types
Prilenia

Prilenia and Ferrer to Present New Pridopidine Data in Huntington’s Disease at HSG Congress

Prilenia and Ferrer Highlight Compelling New Evidence of Pridopidine’s Disease-Modifying Potential in Huntington’s Disease at the 2025 HSG Congress Prilenia Therapeutics B.V. and Ferrer have jointly announced the presentation of five new scientific posters at the 2025 Huntington Study Group…

Read MorePrilenia and Ferrer to Present New Pridopidine Data in Huntington’s Disease at HSG Congress
Biopharma

Vividion Publishes Preclinical Data in Science on Novel RAS-PI3K Inhibitors Blocking Tumor Growth

Vividion Publishes Groundbreaking Science Study on Covalent RAS-PI3Kα Inhibitors That Halt Tumor Growth Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company and wholly owned, independently operated subsidiary of Bayer AG, has announced the publication of a pivotal manuscript in Science…

Read MoreVividion Publishes Preclinical Data in Science on Novel RAS-PI3K Inhibitors Blocking Tumor Growth

Perceptive Imaging Appoints Doug Fulling as CEO to Lead Growth and Innovation

Perceptive Imaging Appoints Doug Fulling as CEO to Lead Global Growth, Enhance Services, and Drive Innovation in Clinical Trial Imaging Perceptive Imaging (“Perceptive” or “the Company”), a global leader in clinical trial imaging services for the pharmaceutical and biotech industries,…

Read MorePerceptive Imaging Appoints Doug Fulling as CEO to Lead Growth and Innovation

Thermo Fisher Launches Molecular Microscope System for Lung Transplant Rejection Detection

Thermo Fisher Scientific Launches Molecular Microscope Diagnostic System to Transform Lung Transplant Rejection Detection and Management Thermo Fisher Scientific Inc., the global leader in serving science, has unveiled an innovative laboratory-developed test (LDT) that aims to revolutionize the detection and…

Read MoreThermo Fisher Launches Molecular Microscope System for Lung Transplant Rejection Detection